Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multiple Ascending Dose Study of the Safety, Tolerability and Bio-effect of Aurase for Wound Debridement in Patients With Venous Leg Ulcers.

NCT04956900 is registered in ClinicalTrials.gov with SolasCure Limited as lead sponsor.

NCT NCT04956900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04956900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multiple Ascending Dose Study of the Safety, Tolerability and Bio-effect of Aurase for Wound Debridement in Patients With Venous Leg Ulcers.
Lead sponsor
SolasCure Limited
Phase
Phase 2
Overall status
Completed
Start date
August 9, 2021
Completion date
February 6, 2023
Enrollment
43 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

leg injuries and disorders, venous leg ulcer